Dr. Reddy’s Laboratories launches antimuscarinic drug Toviaz generic in US
Dr. Reddy’s Laboratories has launched Dr. Reddy’s Fesoterodine Fumarate Extended-Release Tablets in the US market following the approval of the US Food and Drug Administration ... Read More
Dr. Reddy’s Laboratories launches sorafenib generic in US
Dr. Reddy’s Laboratories said that it has launched Dr. Reddy’s Sorafenib Tablets, USP, 200 mg in the US market following the approval of the US ... Read More
Dr. Reddy’s subsidiary Aurigene signs $438m licensing deal with Olema
Dr. Reddy’s Laboratories said that its fully-owned subsidiary Aurigene Discovery Technologies has signed an exclusive global collaboration and license agreement worth up to $438 million ... Read More
Torrent Pharma buys Styptovit-E, Finast, and other brands from Dr. Reddy’s
Torrent Pharmaceuticals has agreed to acquire the Styptovit-E, Finast, Finast-T, and Dynapress brands from Dr. Reddy's Laboratories for an undisclosed price. Styptovit-E is a gynecology ... Read More
Dr. Reddy’s Laboratories launches Pemetrexed for Injection
Dr. Reddy’s Laboratories said that it has launched Pemetrexed for Injection, 100 mg and 500 mg single-dose vials in the US market. Pemetrexed for Injection ... Read More
Dr. Reddy’s, Senores launch Ketorolac Tromethamine Tablets in US
Dr. Reddy’s Laboratories and its partner Senores Pharmaceuticals have launched Ketorolac Tromethamine Tablets USP, 10 mg, in the US market. The launched product is a ... Read More
Dr. Reddy’s Labs launches Posaconazole Delayed-Release Tablets in US
Dr. Reddy’s Laboratories said that it has launched Posaconazole Delayed-Release Tablets, 100 mg, a triazole antifungal drug, in the US market. Posaconazole Delayed-Release Tablets is ... Read More
Dr. Reddy’s to sell and distribute certain Novartis’ products in India
Dr. Reddy's Laboratories has signed an exclusive sales and distribution agreement with Novartis India Limited (NIL) for the latter’s Voveran range, the Calcium range and ... Read More
Dr. Reddy’s gets DCGI approval for single-shot Sputnik Light vaccine
Dr. Reddy's Laboratories said that the Drugs Controller General of India (DCGI) has approved the single-shot Sputnik Light vaccine for restricted use in emergency situation ... Read More
Dr. Reddy’s to acquire German medical cannabis firm Nimbus Health
Dr. Reddy’s Laboratories has agreed to acquire Nimbus Health, a German medical cannabis firm, for an undisclosed price. The Indian pharma company will acquire Nimbus ... Read More